All of the other evaluated variables including age, tumor size, grade, extent of surgery, proportion of hormone receptor positive disease and of left sided tumors had no significant impact on OS, BCSS, and non-breast cancer mortality. This evidence concerns the gene NR4A1 and breast carcinoma.